# Clinical and Translational Study of STA-9090

> **NCT01111838** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 20 (actual)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** STA-9090

## Key facts

- **NCT ID:** NCT01111838
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111838, "Clinical and Translational Study of STA-9090". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01111838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*